Depression
Major depressive disorder affects millions of Americans, causing high costs in both human suffering and medical expenditures. Here in this library you will find hundreds of helpful resources to help in diagnosis and treatment.
Featured Resources
Monoamine Neurotransmitter Dysregulation in Major Depressive Disorder
-
Understanding Neuroplasticity In Depression
InfographicApril 22, 2024The brain is constantly changing! The ability of the brain to create, reorganize, or eliminate connections between neurons (synapses) and… -
Let’s Face It, The Current Treatment Options For MDD Are Not Enough: Learn About Cognitive Emotional Training
On-Demand WebinarFebruary 22, 2024Otsuka Sr. MSL, Dr. Mark Tacelosky spoke with Dr. Brian Iacoviello who guided us through Cognitive Emotional Training for the… -
Understanding MDD Treatments With Neuroplastic Effects
InfographicApril 22, 2024Researchers are exploring whether it is possible to leverage neuroplasticity to develop treatments for depression.
Monoamine Neurotransmitter Dysregulation in Major Depressive Disorder
-
Practical Application of Wellness Strategies for Individuals in Underserved Communities with Major Depressive Disorder (MDD) & Post-Traumatic Stress Disorder (PTSD)
On-Demand WebinarJuly 12, 2024 -
Primary Care PTSD Screen For DSM-5 (PC-PTSD-5)
Downloadable ResourceJune 27, 2024 -
Understanding MDD Treatments With Neuroplastic Effects
InfographicApril 22, 2024
Section Advisors
-
Christine Yu Moutier, MD
Major Depressive Disorder Section Advisor
Ask A Question About Depression
Enter your question in the box below and click “Ask My Question” to submit your inquiry.
You must be logged in to ask a question in this section.
Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
Agitation Associated With Alzheimer’s Dementia Disease State Education
The Importance Of Population Health: A Mental Health Perspective